Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_1
2
50%
Ph phase_4
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)

Trials by Status

completed250%
active_not_recruiting125%
recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingphase_4

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

NCT04033081
recruitingphase_2

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

NCT03290534
completedphase_1

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

NCT02902107
completedphase_1

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

NCT03109041

Clinical Trials (4)

Showing 4 of 4 trials
NCT04033081Phase 4

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

Active Not Recruiting
NCT03290534Phase 2

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Recruiting
NCT02902107Phase 1

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

Completed
NCT03109041Phase 1

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4